Concepedia

Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects

A. Allen, C.C. Asgill, D. M. Pierce, J Upward, Barry D. Zussman

European Journal of Clinical Pharmacology · 1994 · 22 citations · 4 references

DOI

Concepts

References

4

Clinical pharmacokinetics; concepts and applications

General Pharmacology The Vascular System · 1989 · 2.2K citations

, , +12

A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response

J Carmichael, B.M.J. Cantwell, CM Edwards et al. · Cancer Chemotherapy and Pharmacology · 1989 · 169 citations

, , +11

The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.

J Upward, Blake Arnold, C.G.G. Link et al. · PubMed · 1990 · 72 citations

, , +8

Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist

Jim Cassidy, V. Raina, C Lewis et al. · British Journal of Cancer · 1988 · 54 citations · Full text

, , +8